A D S Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve Notice is hereby given pursuant ....
Awaiting price reaction for this filing.
A D S Diagnostics Ltd has informed the BSE that its Board of Directors will meet on Friday, 30th May 2025, at the registered office in New Delhi. The main item on the agenda is to consider and approve the audited financial results of the company for the quarter and financial year ended 31st March 2025. The notice also includes a standard agenda item allowing the Board to transact any other business with the Chairman's permission. The filing has been made under Regulation 29 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and signed by J.L. Gayari, CFO and Company Secretary.
This is a routine procedural filing with no immediate impact on shareholders. Investors should watch for the actual audited Q4 FY25 results, which will be announced after the Board meeting on 30th May 2025 — these numbers will be the key driver of any near-term stock movement.